G. Bradley Cole, General Manager - Diagnostics at EXACT SCIENCES CORP (EXAS), sold 56,032 shares at $80.38 ($4.5M) on 2019-11-21, disclosed to the SEC on 2019-11-25.
Open-market sale of $4.5M EXAS by General Manager - Diagnostics. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.38 | 28,016 | $2.3M | 50.0% |
| 2 | $80.38 | 28,016 | $2.3M | 50.0% |
| Total | $80.38 avg | 56,032 | $4.5M | 100% |
| Filing → |
| EXAS | SELL | 2020-02-21 | $2.7M | — | Filing → |
| EXAS | SELL | 2020-01-17 | $903K | — | Filing → |
| GHDX | SELL | 2019-10-09 | $3.1M | — | Filing → |